Ocata Therapeutics, Inc. Insider Trading for September 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Ocata Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Ocata Therapeutics, Inc. for September 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 26 2014 | ACTC | Ocata Therapeutics ... | Heffernan Michael Thomas | Director | Option Exercise | A | 7.94 | 100,000 | 794,000 | 100,000 | |
| Sep 16 2014 | ACTC | Ocata Therapeutics ... | Anglade Eddy | EVP of Clinical Dev ... | Option Exercise | A | 8.49 | 112,000 | 950,880 | 212,000 | |
| Sep 16 2014 | ACTC | Ocata Therapeutics ... | Anglade Eddy | EVP of Clinical Dev ... | Grant | A | 0.00 | 56,000 | 0 | 56,000 | 0 to 56 K |
| Sep 16 2014 | ACTC | Ocata Therapeutics ... | Lanza Robert | Chief Scientific Of ... | Option Exercise | A | 8.49 | 112,000 | 950,880 | 124,858 | |
| Sep 16 2014 | ACTC | Ocata Therapeutics ... | Lanza Robert | Chief Scientific Of ... | Grant | A | 0.00 | 56,000 | 0 | 231,509 | 175.5 K to 231.5 K (+31.91 %) |
| Sep 16 2014 | ACTC | Ocata Therapeutics ... | Myles Edward H | COO and CFO | Option Exercise | A | 8.49 | 112,000 | 950,880 | 252,000 | |
| Sep 16 2014 | ACTC | Ocata Therapeutics ... | Myles Edward H | COO and CFO | Grant | A | 0.00 | 56,000 | 0 | 56,000 | 0 to 56 K |
| Sep 11 2014 | ACTC | Ocata Therapeutics ... | Lanza Robert | Chief Scientific Of ... | Sell | S | 12.57 | 3,930 | 49,400 | 175,509 | 179.4 K to 175.5 K (-2.19 %) |
| Sep 11 2014 | ACTC | Ocata Therapeutics ... | Lanza Robert | Chief Scientific Of ... | Sell | S | 12.50 | 5,000 | 62,500 | 179,439 | 184.4 K to 179.4 K (-2.71 %) |
| Sep 09 2014 | ACTC | Ocata Therapeutics ... | Lanza Robert | Chief Scientific Of ... | Sell | S | 10.07 | 10,000 | 100,700 | 184,439 | 194.4 K to 184.4 K (-5.14 %) |
| Sep 09 2014 | ACTC | Ocata Therapeutics ... | Lanza Robert | Chief Scientific Of ... | Sell | S | 10.00 | 5,000 | 50,000 | 194,439 | 199.4 K to 194.4 K (-2.51 %) |
| Sep 04 2014 | ACTC | Ocata Therapeutics ... | Lanza Robert | Chief Scientific Of ... | Sell | S | 9.00 | 10,000 | 90,000 | 199,439 | 209.4 K to 199.4 K (-4.77 %) |
| Sep 04 2014 | ACTC | Ocata Therapeutics ... | Lanza Robert | Chief Scientific Of ... | Sell | S | 9.01 | 5,000 | 45,050 | 209,439 | 214.4 K to 209.4 K (-2.33 %) |
| Sep 04 2014 | ACTC | Ocata Therapeutics ... | Lanza Robert | Chief Scientific Of ... | Sell | S | 8.12 | 10,000 | 81,200 | 214,439 | 224.4 K to 214.4 K (-4.46 %) |